background: Using a 3-year nationwide population-based database, this study examines the risk of adverse pregnancy outcomes [lower birthweight, preterm gestation and babies small for gestational age (SGA)] in pregnant women with uterine leiomyoma.
Introduction
Uterine leiomyomas are the most common female genital tumors (Cramer and Patel, 1990; Marshall et al., 1997) . Independent of clinical symptoms, the estimated cumulative incidences were .80% for black women and about 70% for white women when premenopausal women were systematically screened with an ultrasound (Day Baird et al., 2003) . The prevalence of leiomyomata in pregnancy ranges from 0.1 to 3.9% (Rice et al., 1989; Burton et al., 1989; Katz et al., 1989; Hasan et al., 1991; Exacoustos and Rosati, 1993; Coronado et al., 2000; Sheiner et al., 2004; Qidwai et al., 2006) . Laughlin et al. (2009) further reported a higher prevalence (10.7%) among women who underwent a systematic ultrasound screening in the first trimester. Despite the high frequency of uterine leiomyoma occurrence, considerable uncertainty and controversy remain about its effect on pregnancy during the antepartum, intrapartum and post-partum periods (Klatsky et al., 2008) .
The association between maternal uterine leiomyoma and adverse neonatal outcomes remains ambiguous, as existing literature has revealed both supportive and contradictory findings. For example, several studies have reported that women with leiomyoma during pregnancy seem to be at an increased risk of preterm births (Rice et al., 1989; Davis et al., 1990; Exacoustos and Rosati, 1993; Coronado et al., 2000; Sheiner et al., 2004; Qidwai et al., 2006) . Nevertheless, other studies have found no association (Vergani et al., 1994 (Vergani et al., , 2007 Roberts et al., 1999) . There have likewise been varying conclusions regarding the risks of low birthweight (LBW) among children born to mothers with leiomyoma. Although the weight of evidence suggests that women with uterine leiomyoma are not at higher risk for LBW children (Rice et al., 1989; Davis et al., 1990; Exacoustos and Rosati, 1993; Vergani et al., 1994 Vergani et al., , 2007 Roberts et al., 1999) , one population-based study by Coronado et al. (2000) found a higher incidence of LBW in pregnancies with leiomyomata .
Most disagreements between studies probably relate to the varied uterine leiomyoma-detection methods. For instance, some studies were published before the routine use of prenatal ultrasounds and, as such, relied on physical examination and visualization at Cesarean delivery to identify leiomyoma (Rice et al., 1989; Davis et al., 1990) . Moreover, most previous studies have tended to use selective data from one hospital or population subgroup and have had a limited sample size as well as inadequate controls of confounders. This may well account for inconsistent results.
Using a 3-year nationwide population-based database, this study examined the risk of adverse pregnancy outcomes [lower birthweight, preterm birth and small for gestational age (SGA)] in pregnant women with uterine leiomyoma, while taking into consideration the characteristics of both infants and mothers. Taiwan initiated its National Health Insurance Program in 1995, financing healthcare for all of the island's residents. The current data on Taiwan presents a unique opportunity to clarify the relationship between uterine leiomyoma and the risk of adverse pregnancy outcomes.
Methods

Database
We linked two nationwide population-based data sets in this study. The first data set was the Taiwan National Health Insurance Research Data set (NHIRD), released by Taiwan's National Health Research Institute. Taiwan initiated its National Health Insurance (NHI) program in 1995, currently covering over 22 million enrollees and representing .98% of the Taiwanese population. The NHIRD includes all medical claims for enrollees under the NHI program, as well as the registries for contracted medical facilities and board-certified physicians. Therefore, the NHIRD is one of the most comprehensive nationwide population-based data sets available and provides a rare opportunity to examine the risk of adverse pregnancy outcomes among women with uterine leiomyoma.
The second data set was obtained from the Taiwan birth certificate registry, which includes data on birthdates for both infants and parents, gestational week at birth, birthweight, gender, parity, place of birth, parental educational levels and maternal marital status. The government in Taiwan requires all births and deaths to be registered. A study by Lin et al. (2004) verified the completeness and validity of Taiwan's birth registry.
With assistance from the Bureau of the NHI, these two data sets were linked by the unique personal identification numbers of the mother and infant. All personal identifiers were encrypted by the bureau before release to researchers. Since the NHIRD consists of de-identified secondary data released to the public for research purposes, this study was exempt from full review by the Internal Review Board of Taipei Medical University.
Study sample
Our study design featured a study group and a comparison group. In Taiwan, 473 529 pregnant women were identified as having live singleton births between 1 January 2001 and 31 December 2003. If a mother had more than one singleton birth between 2001 and 2003, only the first was selected for the study sample. Pregnant mothers who accepted ultrasound screenings early in their pregnancy (about 52.3% of the source population) were recruited for further selection. Of all these women, 5627 were diagnosed with uterine leiomyoma during pregnancy (ICD-9-CM codes 218, 218.0, 218.1, 218.2 or 218.9).
The comparison group for this study was extracted from the remaining mothers. We randomly selected 28 135 mothers (five for every mother with uterine leiomyoma without matching any trait with the cases). Ultimately, 33 762 women were included in our study sample. The mean gestational age of the receiving 'index' ultrasound screening was 13.2 weeks, with a standard deviation of 9.8 weeks for sampled women.
Variables of interest
The main outcome variables of this study, preterm birth (,37 versus 37 weeks) and SGA (birthweight below the 10th percentile for gestational age), were both dichotomous, whereas birthweight was estimated as a continuous variable. The independent variable of interest was whether or not a mother had been diagnosed with uterine leiomyoma during her index pregnancy. In addition, we further stratified mothers with uterine leiomyoma into intramural only, submucosal only, subserosal only, any two types of leiomyoma combined or unspecified type, and examined their associations with adverse pregnancy outcomes.
We also took into consideration factors from previous literature that were reported to be associated with adverse pregnancy outcomes in the regression modeling. These factors included the characteristics of the mother: age (Cleary-Goldman et al., 2005) , highest educational level (Chen et al., 2009) , marital status (Kirchengast et al., 2007) , year of delivery), infant gender (Ingemarsson, 2003; Di Renzo et al., 2007) , parity and monthly family income . Maternal age was grouped into the following : ,20, 20 -24, 25 -29, 30 -34, 35-39 and 40 . Maternal highest education levels were categorized into the following four levels: elementary school or lower, junior high school, senior high school, college or above. Monthly income was grouped into four categories: ,NT$15 000, NT$15 000-30 000, NT$30 001 -50 000 and NT$50 001 (US$1.00 ¼ NT$ 33.00 in 2003). Furthermore, co-morbid chronic medical conditions such as hypertension (Bruce et al., 2008) , diabetes (Lepercq et al., 2004) , anemia (Xiong et al., 2000) , coronary heart disease (CHD) or hyperlipidemia (Drenthen et al., 2007) were associated with adverse pregnancy outcomes. These illnesses were also related to leiomyomas (Faerstein et al., 2001; Okolo, 2008) . Owing to potential confounding effects, these co-morbid diseases were adjusted in the regression modeling.
Statistical analysis
The SAS statistical package (SAS System for Windows, Version 8.2) was used to perform the analyses in this study. The x 2 tests were carried out to test the differences in the characteristics of mothers and infants, comparing mothers with uterine leiomyoma and unaffected mothers. After adjusting for the characteristics of the mother (age, the highest educational level, marital status and year of delivery), infant (gender and parity), monthly family income and co-morbid illnesses of diabetes, hypertension, anemia, CHD and hyperlipidemia, log-binominal regression analyses were conducted to examine the risk ratio (RR) of preterm birth and SGA among mothers with uterine leiomyoma and unaffected mothers. In addition, a multivariate regression was performed to estimate the relationship between uterine leiomyoma and birthweight after adjusting for gestational age and all of the above-mentioned variables. A twosided P-value of ,0.05 was considered statistically significant for this study.
Results Table I shows the distribution of characteristics of mothers and infants, comparing mothers with uterine leiomyoma and unaffected mothers. The mean age for sampled patients was 28.7 years, with a standard deviation of 5.1 years. The age range was between 17 and 47 years. Among the 5627 sampled mothers with leiomyoma, 24% had intramural only (n ¼ 1348), 10% submucosal only (n ¼ 560), 1.7% subserosal only (n ¼ 98), 1.3% intramural and submucosal combined (n ¼ 75), 0.7% intramural and subserosal combined (n ¼ 39), 0.3% submucosal and subserosal combined (n ¼ 15) and 62% were unspecified (n ¼ 3492). The x 2 tests showed significant differences in maternal age (P , 0.001), highest education level (P , 0.001), marital status (P ¼ 0.001), year of delivery (P , 0.001), monthly family income (P , 0.001), diabetes (P , 0.001), hypertension (P , 0.001), anemia (P , 0.001), CHD (P , 0.001), hyperlipidemia (P , 0.001) and infant parity (P , 0.001) between mothers with uterine leiomyoma and unaffected mothers. In addition, we found that women with uterine leiomyoma had significantly higher percentages of preterm (10.98 versus 7.78%, P , 0.001) and SGA infants (19.00 versus 17.28%, P ¼ 0.002) than unaffected mothers. The mean birthweights for mothers with and without uterine leiomyoma were 3083 g (standard deviation 514 g) and 3172 g (standard deviation 470 g), respectively (P , 0.001). Logbinominal regressions showed that the crude RRs of preterm and SGA infants for mothers with uterine leiomyoma were 1.46 (95% CI 1.33 -1.61) and 1.12 (95% CI 1.04 -1.21), respectively, compared with unaffected mothers.
Finally, after adjusting for the year of delivery, maternal age, highest education level, marital status, family monthly income, hypertension, diabetes, anemia, CHD, hyperlipidemia and infant gender and parity, log-binominal regression models showed that RRs of preterm and SGA infants for women with uterine leiomyoma (in total) were 1.32 (95% CI 1.19 -1.46) and 1.16 (95% CI 1.08 -1.26), respectively, compared with unaffected mothers (Table II) . After adjusting for gestational age and all other listed variables, a multivariate regression revealed that women with uterine leiomyoma had, on average, a 14.7 g lower birthweight than unaffected mothers (P ¼ 0.022).
In further analyzing the relationship between uterine leiomyomas and pregnancy outcomes by type of leiomyoma (intramural only, submucosal only, subserosal only, any two types of leiomyoma combined, unspecified), we found that, compared with unaffected mothers, adjusted RRs of preterm births for mothers with intramural leiomyoma, any two types of leiomyoma combined and unspecified types of uterine myoma were 1.31 (95% CI 1.02 -1.68), 1.26 (95% CI 1.12 -1.42) and 1.32 (95% CI 1.19 -1.48), respectively (not shown in tables). However, no increased risk of preterm births among mothers with submucous leiomyoma and subserosal leiomyoma compared with unaffected mothers were observed. We found that adjusted RRs of SGA infants for mothers with intramural leiomyomas and unspecified types of uterine myoma were 1.15 (95% CI 1.04 -1.27) and 1.19 (95% CI 1.09 -1.29), respectively, compared with unaffected mothers. Regarding infant birthweights, we found that mothers with any two types of leiomyoma combined and unspecified types of uterine myoma, respectively, had 21.1 g (P ¼ 0.032) and 16.5 g (P ¼ 0.018) lower birthweights than unaffected mothers after adjusting for other variables.
Discussion
Uterine leiomyoma commonly affects women in their childbearing years (Practice Committee of the ASRM, 2004). However, to date, the extent to which leiomyoma affects pregnancy is not well established and assessments of the magnitude of pregnancy complications remains inconsistent (Klatsky et al., 2008) . Larger series are therefore required to draw definite conclusions. The present study used a comprehensive large-scale data set in Taiwan to explore the association between mothers with uterine leiomyoma and adverse pregnancy outcomes. We adjusted for traits that demonstrated significant differences between pregnant mothers with and without uterine leiomyoma. It was then observed that women with uterine leiomyoma experienced significantly increased risks for preterm and SGA infants: mothers with uterine leiomyoma were 1.32 and 1.16 times more likely than unaffected mothers to have preterm and SGA babies, respectively; and they had, on average, a 14.7 g lower birthweight than unaffected mothers. However, it is worth noting that clinical significance might be limited due to the small differences in identified birthweight. Within a large sample such as this one, one could argue that statistical significance in even the smallest of differences is bound to appear.
Our results were in line with prior studies by Coronado et al. (2000) , Davis et al. (1990) , Sheiner et al. (2004) , Qidwai et al. (2006) , Exacoustos and Rosati (1993) and Rice et al. (1989) , which consistently found that women with uterine leiomyoma were at an increased risk for preterm infants. They were also consistent with studies by Coronado et al. (2000) and Rosati et al. (1992) , which found a significant relationship between uterine leiomyoma and LBW and SGA. However, since previous studies have depended on selective data, such as data limited to one hospital or population subgroup, their findings may not reflect the full spectrum of pregnancy experiences across a country (Rice et al., 1989; Davis et al., 1990; Exacoustos and Rosati, 1993; Coronado et al., 2000; Sheiner et al., 2004; Qidwai et al., 2006) . Moreover, as far as we have known, all such studies were conducted in Western countries; therefore, our findings not only add further evidence to the increased risk of preterm and SGA births for women with uterine leiomyoma, but also extend the literature to include the experiences of an Asian population.
Some prior studies have failed to observe an association between uterine leiomyoma and increased risks of preterm births (Vergani et al., 1994 (Vergani et al., , 2007 Roberts et al., 1999) and/or LBW (Rice et al., 1989; Davis et al., 1990; Exacoustos and Rosati, 1993; Vergani et al., 1994 Vergani et al., , 2007 Roberts et al., 1999) . One possible explanation for the difference is the diverse methods of detecting uterine leiomyoma. For example, some studies were conducted before the routine use of prenatal ultrasound and consequently included fibroids diagnosed primarily during physical examination, laparotomy or manual removal of the placenta after delivery (Rice et al., 1989; Davis et al., 1990) . Furthermore, some studies used ultrasounds, but only in select patient populations, such as in older or pregnant women with a uterus size greater than expected for the gestational stage, cases of vaginal bleeding or malpresentation or women presenting for routine genetic testing (Exacoustos and Rosati, 1993; Vergani et al., 1994 Vergani et al., , 2007 Continued allowed to have 10 free scheduled prenatal care visits, which include routine ultrasound examinations. Therefore, in contrast to prior studies that may underestimate the prevalence of leiomyomata, in this study, all of the pregnant women received routine ultrasonographic screenings for uterine leiomyomata. The prevalence of leiomyomata reported in the present study (1.19%) was higher than that found by other studies (e.g. 0.37% by Coronado et al. (2000) and 0.65% by Sheiner et al. (2004) ).
Another explanation for the inconsistent findings of prior studies could be the failure to take location or type of uterine leiomyoma into consideration. In our study, we separated women with uterine leiomyoma into five groups according to location in order to explore associations in pregnancy outcomes. Specifically, women with intramural leiomyoma only, any two types combined and unspecified types of uterine leiomyoma were more likely to have preterm births than unaffected mothers, although women with submucosal leiomyoma were the only group to not have an increased risk of adverse birth outcomes. In a review of the literature, Klatsky et al. (2008) stated that no conclusive evidence was reached to determine whether certain types of uterine leiomyoma might adversely affect the pregnancy outcome. Because the majority of women (44.3%) in our study were coded as an unspecified type, more studies are required to further assess the various effects of leiomyoma types on birth outcomes.
The mechanism underlying the association between uterine leiomyoma and adverse pregnancy outcomes remains unclear. Some investigators have suggested that physical interference leading to decreased uterine distensibility or mechanical obstructions that restrict space, limit fetal movement or lessen the force of contractions likely play a role. Further prospective studies are required to identify the concurrent roles of biologic, metabolic or immune factors relating to uterine leiomyoma and pregnancy outcomes.
Our study utilized a nationwide population-based data set with a large sample size for analysis. Linking the NHIRD with the National Birth Registry also left little room for selection and non-response bias. The robust findings in our study might be generalized to the population as a whole, especially for those with similar compositions of population traits to Taiwan.
Despite the strength of our study, caution must be heeded due to the following limitations. First, fibroids might have been selectively detected because a standardized protocol for screening fibroids with a research-quality ultrasonography was unavailable. With the use of a claims data set in our study, uterine leiomyoma identification largely relied on clinically experienced technicians or sonographers.
In general, the Muram criteria for modification was widely applied to define the presence of uterine fibroids (Muram et al., 1980) . It is possible that fibroids were more likely to be detected in women who sought care for bleeding and/or pain during pregnancy. These women also had higher risks of adverse pregnancy outcomes. However, in further analyzing our data, we found that most women with fibroids were detected during regular prenatal care visits. The timing of the ultrasound screening might be an issue because fibroids could be difficult to detect during the second and third trimesters when the placenta and fetus were enlarging. As the prenatal care in Taiwan usually begins prior to the 12 weeks of gestation based upon last menstrual period, the mean gestational age of the receiving 'index' ultrasound screening in our study was 13.2 weeks, with a standard deviation of 9.8 weeks. A total of 73.8, 25.2 and 1% of fibroids were detected during the first, second and third trimester of the medical records, respectively. Second, the NHIRD lacks clinical information and therefore did not allow us to differentiate study participants according to size and number of leiomyomas. In addition, it is possible that some clinically unimportant tumors were detected. The associations reported were thus likely underestimates.
Third, although ICD-9 CM codes of uterine leiomyoma do not identify location (e.g. fundus, lower segment), fibroids are usually classified by location, such as the submucous or intramural type. Our results might be limited in assessing the association between types of uterine leiomyoma and adverse pregnancy outcomes, as the majority of women (44.3%) in our study were coded as an unspecified type. The detection of the location might also vary based upon operational definitions and clinical experience in various medical settings.
Finally, although we adjusted for some potential maternal and pregnancy-specific confounders, information such as mother's smoking history, substance abuse, alcohol consumption, nutrition and body mass index (particularly pre-pregnancy maternal body mass index) was not available in our data sets. The impact of these unmeasured factors may vary. For example, a lack of control for smoking would not have explained the positive findings because, in medical literature, maternal smoking has either been inversely (Baron, 1996; Wolf et al., 2004; Templeman et al., 2008) or unassociated (Marshall et al. 1998; Wise et al. 2004) with the risk of fibroids, and positively associated with the risk of LBW and preterm birth (Horta et al., 1997; Chiolero et al., 2005) . However, a lack of control for maternal body mass index, nutritional status and alcohol consumption might be a concern because they are positively Continued associated with both uterine leiomyoma (Wise et al., 2004; Terry et al., 2007) and adverse birth outcomes (Lim et al., 2007; O'Leary et al., 2009 ). Our study is prominent in utilizing an extensive and unselected nationwide population-based study to assess the risks of adverse pregnancy outcomes among women diagnosed with uterine leiomyoma. We found that after adjusting for potential confounders, women with uterine leiomyoma during pregnancy had significantly higher risks of preterm and SGA babies, compared with unaffected mothers. Although the risks are significantly elevated, they are also very small. We suggest that clinicians inform women with uterine leiomyomas of the potential risks before planning a child and offer more intensive monitoring and prenatal care during pregnancy. Multivariate regression was used to estimate the risks of birthweight, whereas log-binomial regressions were performed to assess the risks of preterm birth and SGA. The estimates presented are adjusted for all other variables listed in the table. *P , 0.05; **P , 0.01; ***P , 0.001.
